American Electric Power vs CenterPoint Energy
AEP and CNP side by side, both in electric services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AEP and CNP compare
American Electric Power is the larger company, worth 2.5 times as much as CenterPoint Energy ($70.9B against $28.0B).
On earnings, American Electric Power is cheaper: it trades at 22.5× trailing earnings, against 25.0× for CenterPoint Energy.
American Electric Power grew revenue faster over the last twelve months (10.3% versus 7.1% for CenterPoint Energy).
Both pay dividends: American Electric Power yields 2.9% and CenterPoint Energy 2.2%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AEP | CNP |
|---|---|---|
| Size and price | ||
| Market cap | $70.9B | $28.0B |
| Share price | $130.21 | $42.44 |
| Change, 1 year | 6.6% | 9.0% |
| Change, 5 years | 53.1% | 59.1% |
| Beta (5Y) | 0.24 | 0.40 |
| Employees | 18K | 3,712 |
| StockData Score | ||
| Total score | 6 | 6 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 1 |
| Performance score | 0 | 2 (better) |
| Health score | 0 | 1 (better) |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/E | 22.5× (better) | 25.0× |
| P/S | 3.1× | 2.9× (better) |
| P/B | 2.2× (better) | 2.4× |
| EV/EBITDA | 23.7× | 12.9× (better) |
| P/FCF | 16.5× | – |
| PEG | 1.60 (better) | 119.33 |
| FCF yield | 6.0% (better) | −9.6% |
| Fair value | $105.39 | $36.12 |
| Margin of safety | −23.5% | −17.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 10.3% (better) | 7.1% |
| Revenue growth, 5Y average | 8.0% (better) | 4.8% |
| Net income growth (TTM) | – | 19.3% |
| EPS growth (TTM) | −15.2% | 18.9% (better) |
| EPS growth, 5Y average | 8.5% | – |
| Profitability | ||
| Gross margin | 67.7% | 100.0% (better) |
| Operating margin | 23.0% | 23.2% (better) |
| Net margin | – | 11.6% |
| FCF margin | 18.8% (better) | −28.0% |
| Return on equity | – | 9.8% |
| Return on invested capital | 5.9% (better) | 5.8% |
| Financial health | ||
| Debt / equity | 1.65 (better) | 1.95 |
| Net debt / EBITDA | 9.96 | 5.76 (better) |
| Interest coverage | 2.4× (better) | 2.2× |
| Current ratio | 0.50 | 1.12 (better) |
| Altman Z-score | 0.93 (better) | 0.90 |
| Piotroski F-score | – | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.9% (better) | 2.2% |
| Payout ratio | – | 52.7% |
| Years of dividend growth | 16 (better) | 3 |
| Dividend growth, 5Y average | 5.7% | – |
| Buyback yield | −1.5% | – |
| Shareholder yield | 1.4% | 2.2% (better) |
| Ownership | ||
| Held by institutions | 92.2% | 106% |
| Held by insiders | 0.10% | 0.30% |
| Insider net buying, 12 months | −$2.2M | −$200K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.4% | 7.4% |
Go deeper
- AEP stock overview
- AEP income statement
- AEP valuation and score
- CNP stock overview
- CNP income statement
- CNP valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.